Bal Harbour, Fla. - The use of topically applied immune response modifier imiquimod (Aldara) goes beyond its FDA-approved application for the treatment of genital and perianal warts.
The Weekly Roundup: September 18-22
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Colloidal Oatmeal Effective in Improving Atopic Dermatitis in Black Children
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Frontline Forum Part 4: Improving Basal Cell Carcinoma Management
Native American and Indigenous Communities Face Dermatologic Barriers to Care, Disparities, and More
2 Clarke Drive Cranbury, NJ 08512